Mangrove Partners Corbus Pharmaceuticals Holdings, Inc. Put Options Transaction History

Mangrove Partners

  • $769 Million
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$0.94 - $1.89 $1.99 Million - $3.99 Million
-2,112,200 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$1.5 - $9.38 $3.14 Million - $19.6 Million
2,090,900 Added 9816.43%
2,112,200 $3.8 Million
Q2 2020

Aug 14, 2020
BUY
$4.79 - $8.39 $102,027 - $178,707
21,300 New
21,300 $179,000

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $2.08B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Mangrove Partners Portfolio

Follow Mangrove Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email